NCT05147532RecruitingPhase 3
Remyelination in Multiple Sclerosis: a PET-MR longitudinal study investigating individual profiles of myelin repair and the contribution of neuroinflammation (SMART in MS)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 23 Oct 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 31 Oct 2024
- Start date
- 24 Jan 2022
- Lead sponsor
- Assistance Publique Hopitaux De Paris
- Diseases
- Multiple sclerosis
- NCT number
- NCT05147532
- EU CT number
- 2024-512761-13-00
- EudraCT number
- 2021-002334-16
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 60
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Groupe Hospitalier Nord Essonne Coordinator of this site? Confirm its status | Orsay | France | Recruiting |
| Assistance Publique Hopitaux de Paris Coordinator of this site? Confirm its status | Paris | France | Recruiting |
| Institut Du Cerveau Et De La Moelle Epiniere Coordinator of this site? Confirm its status | Paris | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.